- Perindopril erbumine 4mg/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Perindopril erbumine 4mg/5ml oral suspension | Start Date 19-03-2013 | End Date |
Previous Name | Previous Name Perindopril 4mg/5ml oral suspension | Start Date 23-11-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- C09AA04
- BNF Codes
-
- BNF code 02050501
Code | Start Date | End Date |
---|---|---|
8671311000001103 | 23-11-2004 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Perindopril erbumine | Based on Ingredient Substance | 800 microgram | 1 ml |
Name
Perindopril erbumine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
800
Strength and UOM (Dmr)
1
Parent Products
-
VTMPerindopril erbumine
-
VMP(Current) Perindopril erbumine 4mg/5ml oral su...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml | 8 | Part VIIIB |
100 ml | 1791 | Part VIIIB |